A man who was paralyzed seven years ago can walk and stand on his own after taking part in a stem cell study at Rochester, Minn.-based Mayo Clinic, ABC News reported April 1.

Cassandra Lee, MD, recently became one of the first surgeons in the U.S. to use the CartiHeal Agili-C cartilage repair implant.

SurGenTec's OsteoFlo hydroputty synthetic bone graft earned 510(k) clearance from the FDA, the medtech company said March 7.

Bone Biologics, a company focused on spine fusion products, recently announced a $2 million public offering.

In February, Zimmer Biomet closed on the acquisition of orthobiologics company Embody for $155 million. Embody focuses on soft tissue healing, and its portfolio includes the Tapestry biointegrative implant for tendon healing and Tapestry RC implant for rotator cuff repair.

Regenerative medicine has been growing in orthopedics, and there's one important element that can push it forward in the field.

Here are four biologics updates Becker's has reported on since Dec. 13:

RTI Surgical signed an agreement to acquire Cook Biotech, according to a Jan. 8 news release. 

Kuros Biosciences hit three advancements for its MagnetOS portfolio, according to a Jan. 4 news release. 

Ossium Health's OssiGraft viable bone matrix allograft was used in its first patient case, according to a Dec. 14 news release.

Legislation has been introduced in the U.S. House that would require all bone graft material to be tested for active and latent tuberculosis. It would also expedite the process for developing a screening test, according to a Dec. 13 report from The Detroit News. 

Medical device company Alafair Biosciences has surpassed 12,000 implantations of its flagship product VersaWrap, the only class II medical device intended for use on tendon, ligament, skeletal muscle and peripheral nerve, including on nerve root in spine procedures. 

Orthopedic devicemaker Paragon 28 launched the Beast cortical fibers, the company said Nov. 14.

Here are three key updates on spine and orthopedic biologics since Oct. 10.

David Karli, MD, has opened an orthopedic regenerative medicine center focusing on bone marrow concentrate and micronized fat stem cell therapies in Miami, Fla.

Regenerative orthopedic developer Advanced Biologics has merged with orthobiologic firm Isto Biologics, according to an Oct. 24 report from the North Coast Current.

DiscGenics is partnering with the U.S. Department of Veterans Affairs to conduct research into forming tissue-engineered discs, according to an Oct. 18 news release.

Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.

Here are 11 key updates on orthobiologics from the third quarter of 2023:

Researchers at New York City-based Hospital for Special Surgery and Weill Cornell Medicine discovered a new stem cell that could affect spine care.